Scientists create cellular map to track lymphoma
NCT ID NCT04696692
First seen Nov 18, 2025 · Last updated May 17, 2026 · Updated 23 times
Summary
This study looked at 60 people with a type of blood cancer called diffuse large B-cell lymphoma. Researchers used advanced techniques to examine individual cells from tumors and blood samples. The goal was to find markers that could help track how the disease changes over time and how well treatment is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.